Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.

Abstract A survey of 48 adult epileptic outpatients receiving chronic combined phenobarbital and diphenylhydantoin therapy demonstrated significant hypocalcemia in 19 per cent, and significantly decreased serum 25-hydroxycalciferol in 33 per cent of patients, as compared to 38 untreated controls. Similar but less marked changes were seen in a group of 13 patients given chronic therapy with either phenobarbital or diphenylhydantoin alone. Elevation of serum alkaline phosphatase in the patients receiving chronic therapy with either or both of these agents was attributable to increases in both the hepatic and bone isoenzyme fractions. Serum calcium correlated positively with serum 25-hydroxycalciferol in both the patient and the control groups. Serum 25-hydroxycalciferol also correlated positively with vitamin D intake in the patient and control groups, but at any given intake of vitamin D, mean serum levels were lower in the patient group. Lowest serum calcium and 25-hydroxycalciferol levels were seen in th...

[1]  L. Avioli,et al.  Phenobarbital-induced alterations in vitamin D metabolism. , 1972, The Journal of clinical investigation.

[2]  J. Haddad,et al.  25-Hydroxycholecalciferol-binding globulin in human plasma , 1971 .

[3]  J. Haddad,et al.  COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1 , 1971 .

[4]  S. Birge,et al.  25-Hydroxycholecalciferol: specific binding by rachitic tissue extracts. , 1971, Biochemical and biophysical research communications.

[5]  J. Maxwell,et al.  Altered Calcium Metabolism in Epileptic Children on Anticonvulsants , 1971, British medical journal.

[6]  E. Mawer,et al.  The apparent vitamin D resistance of chronic renal failure. A study of the physiology of vitamin D in man. , 1971 .

[7]  A. Richens,et al.  Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy , 1970, British medical journal.

[8]  A. Richens,et al.  Disturbance of Calcium Metabolism by Anticonvulsant Drugs , 1970, British medical journal.

[9]  D. Rowe,et al.  Electrophoretic separation of tissue-specific serum alkaline phosphatases , 1970, Journal of clinical pathology.

[10]  F. H. Tyler,et al.  Effect of diphenylhydantoin on the metabolism of dexamethasone. , 1970, The New England journal of medicine.

[11]  H. DeLuca,et al.  25-hydroxyergocalciferol: a biologically active metabolite of vitamin D2. , 1969, Biochemical and biophysical research communications.

[12]  H. DeLuca.  25-Hydroxycholecalciferol, the probable metabolically active form of vitamin D. Isolation, identification, and subcellular location. , 1969, The American journal of clinical nutrition.

[13]  R. Kruse.  [Osteopathies in antiepileptic long-term therapy (preliminary report)]. , 1968, Monatsschrift fur Kinderheilkunde.

[14]  A. Conney.  Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.

[15]  W. Loomis.  Skin-Pigment Regulation of Vitamin-D Biosynthesis in Man , 1967, Science.

[16]  A. Conney,et al.  Effect of chronic phenobarbital treatment on the liver microsomal metabolism and uterotropic action of 17-beta-estradiol. , 1967, Endocrinology.

[17]  H. Rasmussen,et al.  Further studies on the interrelationship between parathyroid hormone and vitamin D. , 1966, The Journal of clinical investigation.

[18]  A. Glazko,et al.  Studies on 5, 5'-diphenylhydantoin (dilantin) in animals and man. , 1956, The Journal of pharmacology and experimental therapeutics.